Platelets Rich Plasma (PRP) Procedure in the Healing of Atonic Wounds.
Maur Sebastian HorgosOvidiu Laurean PopMircea I SandorIoan Lucian BorzaRodica Anamaria NegreanAdrian CoteAndreea-Adriana NeamtuCarmen GrierosuSachelarie LilianaAnca C HuniadiPublished in: Journal of clinical medicine (2023)
(1) Background: Patients suffering from chronic wounds report physical, mental, and social consequences due to their existence and care. There is a global need for tissue repair strategies and, in our case, for chronic wound healing. PRP therapy is based on the fact that platelet-derived growth factors (PGF) support the three phases of the wound healing and repair cascade (inflammation, proliferation, and remodeling); (2) Methods: A comparative study was carried out on two groups of patients with atonic wounds totaling a total of 80 cases as follows: a study group in which the PRP procedure was applied and a control group in which the biological product was not injected. The study was carried out in the surgery clinic of the Clinical Hospital C.F. Oradea City; (3) Results: A much faster healing was achieved in the case of patients who benefited from the platelet-rich plasma injection therapy compared to the group of patients in whom this therapy was not used. Three weeks after the plasma injection, a considerable reduction of the wound was evident, with some of the patients presenting with a closed wound; (4) Conclusions: The effect of PRP on the healing of chronic wounds is promising in most cases. A positive effect was also highlighted in terms of reducing treatment costs by considerably reducing the materials used as well as the number of hospitalizations for the same pathology.
Keyphrases
- platelet rich plasma
- wound healing
- end stage renal disease
- healthcare
- ejection fraction
- minimally invasive
- newly diagnosed
- chronic kidney disease
- mental health
- peritoneal dialysis
- primary care
- oxidative stress
- signaling pathway
- palliative care
- prognostic factors
- emergency department
- stem cells
- ultrasound guided
- cell therapy
- quality improvement
- drug induced
- health insurance
- atrial fibrillation
- coronary artery bypass
- preterm birth
- replacement therapy